CardioMech
PrivateLast Round
Convertible Debt
Jan 2, 2024
Total Funding Raised
$39M
Company Overview
CardioMech operates in Healthcare & Life Sciences and is based in Trondheim. Its latest recorded funding round was a Convertible Debt round in January 2024.
CardioMech is a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology for patients with degenerative mitral regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CardioMech Comparables
Compare CardioMech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CoreMedic | 94% | |
| Vesalius Cardiovascular | 93% | |
| Polares Medical | 89% |
For institutional investors. Book with your work email.
CardioMech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jan 2, 2024 | ||||
| Series A | Aug 5, 2020 | ||||
| Convertible Debt | Aug 12, 2019 | ||||
| Convertible Debt | Feb 11, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CardioMech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investinor | Convertible Debt, Series A |
| Hadean Ventures | Series A |
Recent news
Latest coverage and updates
- is_developingSep 2, 2026
CardioMech Inc. is developing a transcatheter mitral valve repair platform for DMR treatment as a less-invasive option for mitral regurgitation.
For institutional investors. Book with your work email.
CardioMech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CardioMech's valuation, stock price, and market status.
Is CardioMech a public or private company?
CardioMech is a private company.
What is the current stock price of CardioMech?
CardioMech is a private company, so its shares have no public market price. Caplight tracks CardioMech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CardioMech worth (valuation)?
Valuation information for CardioMech is not publicly available.
Can I buy CardioMech stock?
CardioMech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CardioMech's last funding round?
CardioMech's most recent funding round was Convertible Debt on January 2, 2024.
Who are the main investors in CardioMech?
Key investors in CardioMech include Investinor, Hadean Ventures.
Will CardioMech IPO soon?
No public IPO plans have been announced for CardioMech.
How can I track CardioMech secondary market activity?
Caplight tracks bids, offers, and trades in CardioMech's shares on secondary markets.